Johnson DW - Search Results

1

Treatment of peritoneal dialysis-associated peritonitis: a systematic review of randomized controlled trials.

Wiggins KJ, Johnson DW, Craig JC, Strippoli GF. Wiggins KJ, et al. Among authors: johnson dw. Am J Kidney Dis. 2007 Dec;50(6):967-88. doi: 10.1053/j.ajkd.2007.08.015. Am J Kidney Dis. 2007. PMID: 18037098 Review.

2

Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis.

Hawley CM, Wall DR, Johnson DW, Campbell SB, Griffin AD, Rigby RJ, Petrie JJ. Hawley CM, et al. Among authors: johnson dw. Am J Kidney Dis. 1995 Oct;26(4):658-61. doi: 10.1016/0272-6386(95)90605-3. Am J Kidney Dis. 1995. PMID: 7573023

3

Is obesity a favorable prognostic factor in peritoneal dialysis patients?

Johnson DW, Herzig KA, Purdie DM, Chang W, Brown AM, Rigby RJ, Campbell SB, Nicol DL, Hawley CM. Johnson DW, et al. Perit Dial Int. 2000 Nov-Dec;20(6):715-21. Perit Dial Int. 2000. PMID: 11216565

4

Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients.

Johnson DW, Kay TD, Vesey DA, Isbel N, Campbell SB, Hawley CM. Johnson DW, et al. Perit Dial Int. 2000 Nov-Dec;20(6):766-71. Perit Dial Int. 2000. PMID: 11216572

5

Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

Herzig KA, Purdie DM, Chang W, Brown AM, Hawley CM, Campbell SB, Sturtevant JM, Isbel NM, Nicol DL, Johnson DW. Herzig KA, et al. Among authors: johnson dw. J Am Soc Nephrol. 2001 Apr;12(4):814-821. doi: 10.1681/ASN.V124814. J Am Soc Nephrol. 2001. PMID: 11274243

6

Oral versus intravenous iron supplementation in peritoneal dialysis patients.

Johnson DW, Herzig KA, Gissane R, Campbell SB, Hawley CM, Isbel NM. Johnson DW, et al. Perit Dial Int. 2001;21 Suppl 3:S231-5. Perit Dial Int. 2001. PMID: 11887827

7

Correlates of subclinical left ventricular dysfunction in ESRD.

Fathi R, Isbel N, Haluska B, Case C, Johnson DW, Marwick TH. Fathi R, et al. Among authors: johnson dw. Am J Kidney Dis. 2003 May;41(5):1016-25. doi: 10.1016/s0272-6386(03)00199-9. Am J Kidney Dis. 2003. PMID: 12722036

8

Predictors of decline of residual renal function in new peritoneal dialysis patients.

Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Hollett P. Johnson DW, et al. Perit Dial Int. 2003 May-Jun;23(3):276-83. Perit Dial Int. 2003. PMID: 12938830

9

The effect of long-term aggressive lipid lowering on ischemic and atherosclerotic burden in patients with chronic kidney disease.

Fathi R, Isbel N, Short L, Haluska B, Johnson D, Marwick TH. Fathi R, et al. Am J Kidney Dis. 2004 Jan;43(1):45-52. doi: 10.1053/j.ajkd.2003.09.012. Am J Kidney Dis. 2004. PMID: 14712426 Clinical Trial.

10

Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients.

Rumpsfeld M, McDonald SP, Purdie DM, Collins J, Johnson DW. Rumpsfeld M, et al. Among authors: johnson dw. Am J Kidney Dis. 2004 Mar;43(3):492-501. doi: 10.1053/j.ajkd.2003.11.010. Am J Kidney Dis. 2004. PMID: 14981608

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,694 results

Search Page

Filters